SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-075436
Filing Date
2024-03-22
Accepted
2024-03-22 17:10:05
Documents
15
Period of Report
2024-03-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d56043d8k.htm   iXBRL 8-K 28598
2 EX-10.1 d56043dex101.htm EX-10.1 19476
6 GRAPHIC g56043g0321231537148.jpg GRAPHIC 3226
  Complete submission text file 0001193125-24-075436.txt   177657

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gh-20240318.xsd EX-101.SCH 2853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20240318_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20240318_pre.xml EX-101.PRE 10816
18 EXTRACTED XBRL INSTANCE DOCUMENT d56043d8k_htm.xml XML 3496
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 24776150
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)